Sonim Technologies Inc completed its acquisition of Dna X LLC on 2025-12-15, according to the Form 8-K Sonim Technologies Inc filed with the SEC on 2025-12-18. The filing states a price of $1.2 million.
| Acquirer | Sonim Technologies Inc |
|---|---|
| Acquired | Dna X LLC |
| Completed | 2025-12-15 |
| Price stated in the filing | $1.2 million |
| Reported by | Sonim Technologies Inc (SONM), the buyer |
| Filing | Form 8-K, filed 2025-12-18 |
Want the whole picture on Sonim Technologies Inc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Sonim Technologies Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sonim Technologies Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What the filing says
In connection with the Offering, on the same date and concurrently with the closing of the sale of the DNA Note, the Company also entered into a membership interest purchase agreement with DNA Holdings (the "Membership Interest Purchase Agreement" and, together with the Purchase Agreement and the DNA Note, the "Transaction Documents"), pursuant to which the Company purchased 100% of the membership interests in DNA X LLC, a Delaware limited liability company, ("DNA X") for an aggregate purchase price of 223,201 shares of the Company's common stock, representing 19.99% of the outstanding shares of the Company's common stock as of the date of issuance.
The price, in the filing's words
The cash proceeds disbursed to the Company from the issuance of the DNA Note were $1,200,000.
More from the filing
Entry into a Material Definitive Agreement.
Note Offering and Purchase of Membership Interest On December 15, 2025, Sonim Technologies, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with DNA Holdings Venture, Inc. ("DNA Holdings") and issued a convertible promissory note in the original principal amount of $1,200,000 (the "DNA Note"), in a private placement (the "Offering").
The Company paid no placement agent fees in connection with the Offering.
Quoted from Sonim Technologies Inc's Form 8-K.
This is the only completed acquisition Sonim Technologies Inc reported under Item 2.01 in the last twelve months.
Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Sonim Technologies IncLook up Sonim Technologies Inc and see what is on record before you decide.
Get the free SnapshotWhere this comes from
A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.
Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.